Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Stifel starts Cytokinetics stock with Buy, $80 target
Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of $80.00. The new coverage comes after a period of instability for the company,
Fastenal price target lowered to $82 from $86 at Stifel
Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the Q4 revenue and AEBITDA miss, the shares traded up on optimism for higher growth and margin improvement in FY25.
Planet Fitness price target raised to $90 from $85 at Stifel
Stifel analyst Chris O’Cull raised the firm’s price target on Planet Fitness (PLNT) to $90 from $85 and keeps a Hold rating on the shares after
Stifel cuts Inspire Medical stock target to $190 from $200
Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision follows a period of fluctuating stock performance and a recent presentation by the company's management.
GlobalData on MSN
20h
Morgan Stanley, Stifel/KBW lead 2024 M&A financial adviser rankings in financial services sector
Morgan Stanley topped by deal value with $96bn in deals while Stifel/KBW led by deal volume with 37 transactions.
6d
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
24/7 Wall St
11h
2025 Bull Market: Here's How High These Wall Street Analysts Think the Market Could Go In 2025
Wall Street analysts are buzzing with optimism as we step into 2025. There are plenty of reasons for a positive view to ...
bovnews
15h
Why Did Stifel Give Altimmune Inc (ALT) Stock Buy Rating?
Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...
4d
on MSN
Debt limit will add 'complexity' to Trump agenda, says Stifel's Brian Gardner
Brian Gardner, Stifel chief Washington policy strategist, joins 'Closing Bell Overtime' to talk how to play the Trump trade ...
4d
on MSN
Rapid7, Tenable cut to Hold at Stifel on low priority of vulnerability management
Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.
Legal Sports Report
4d
Stifel Initiates FanDuel Parent Flutter With Buy Rating
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
11d
What Analysts Are Saying About Stifel Financial Stock
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
4d
Procter & Gamble price target lowered to $161 from $167 at Stifel
Stifel analyst Mark Astrachan lowered the firm’s price target on Procter & Gamble (PG) to $161 from $167 and keeps a Hold rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Trade
New York Stock Exchange
Nasdaq
Canadian National Railway
Q4
Feedback